ANTIBODIES SPECIFIC FOR PHOSPHORYLATED INSULIN RECEPTOR SUBSTRATE-1/2 (SER 1101/SER1149) AND USES THEREOF

Details for Australian Patent Application No. 2003287453 (hide)

Owner CELL SIGNALING TECHNOLOGY, INC.

Inventors POLAKIEWICZ, Roberto; WU, Jiong; LI, Yu

Pub. Number AU-A-2003287453

PCT Number PCT/US2003/0348

PCT Pub. Number WO2004/039963

Priority Not Given 29.10.03 US; 60/422,409 30.10.02 US

Filing date 29 October 2003

Wipo publication date 25 May 2004

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): Not Given 29.10.03 US; 60/422,409 30.10.02 US

24 June 2004 Application Open to Public Inspection

  Published as AU-A-2003287453

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287454-DRIVER-ACCESSIBLE STORAGE COMPARTMENTS FOR PASSENGER VEHICLES

2003287452-CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING